IDEXX Laboratories, Inc. (IDXX)

Nasdaq · Healthcare · Diagnostics & Research
$676.21-1.95%As of 2026-11-22 · USD
Last session low $672.75Last session high $696.89
52-week low $500.6152-week high $769.98
Market cap
$53.28B
Sector
Healthcare
P/E (TTM)
45.6x
Next earnings
2027-02-01 (est.)

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)62.0In the neutral range (30 to 70)
MACD (12, 26, 9)35.34Below its signal line (38.18); histogram -2.84
Bollinger %B (20, 2)58%Inside the bands (547.28 to 770.77)
SMA 20659.02Price is 2.6% above
SMA 50580.00Price is 16.6% above
SMA 200573.51Price is 17.9% above
ATR (20)3.14% of priceAverage true range per day
52-week position65%In the middle of the 500.61 to 769.98 range

About IDEXX Laboratories, Inc.

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy.

Insider filings, 90 daysNo purchases and 4 sales (about $25.8M).
Latest fiscal yearEnded 2025-12-31: revenue of $4.30B and an operating margin of 31.6%.
Next earnings reportExpected on 2027-02-01 (the date is an estimate).

More in Diagnostics & Research